Board of Advisors
Our firm has attracted a group of advisors who are nationally recognized in specific knowledge areas. Each has agreed to assist us in strategy and contacts as needed.
 |
Terrance (“Terry”) Bruggeman serves as a Chairman and Chief Executive Officer of Aspetuck Capital Partners, Inc., a life science and technology focused investment banking firm. Aspetuck provides strategic advice, collaboration development, merger and acquisition and restructuring advice to the biotechnology and medical device industries. Mr. Bruggeman has advised companies and their boards, creditor and equity security holder committees as well as served as interim CEO in a wide range of industries. He has been frequently called upon to provide “expert testimony” in various bankruptcy courts.
Mr. Bruggeman’s career has included: general partner of a private equity firm; COO and CEO of private equity and venture–backed companies, co-founder of a leasing company; Treasurer and CFO of two NYSE listed public companies; and an investment banker focused on the restructuring underperforming and troubled companies. (more)
Richard DayFounder, CEO – Daycom Systems, Inc.
Rick Day is founder and CEO of Daycom Systems, a premier voice communications VAR based in San Diego. Rick’s experience includes nearly 20 years in the computer and telecommunications industries with an emphasis on mid-range systems. After five successful years in the secondary market for IBM and AT&T equipment, he started Daycom Systems in 1992. Rick has grown the company, and transformed its operations and value proposition, substantially, several times in the fast-changing telecom industry. Daycom is now a leading communications VAR and maintenance provider with over $20 million in annual sales.
Daycom consults, designs, installs, integrates, and maintains voice communications, messaging, and call center systems for medium and large commercial businesses nationwide. The company currently employs more than 50 employees, and has over 300 commercial customers nationwide – names like: Wal-Mart, Geico, Mutual of Omaha, Intel, AARP, and many others. The company carries four major product lines – Avaya, Nortel, Siemens, and Cisco, as well as a fully array of value-added, Daycom-branded services.
Rick has developed substantial expertise in strategic decision-making initiatives, specific goal-setting, corporate communications, building and evolving management teams, building boards for privately-owned businesses, M&A activities, and in leading financial, sales, and operations management.
Rick is on the Board of Advisors for Bente Hansen & Associates, and serves as Director on the Boards of Power Lifestyles International and Sequoia Asset Management Group.
Rick is past President of the North American Telecommunications Dealers Association (NATD), a professional trade group that ensures the highest ethical standards among telecommunications dealers. Rick also served on the Vendor Liaison Committee for the American College and University Telecommunications Association (ACUTA), and served two years on Avaya’s BusinessPartner Advisory Council. Rick has a BS Degree in Finance from San Diego State University and is a veteran of the US Navy (’82 – 87’). Back to Top
Ginger L. Graham
Ginger L. Graham, President and CEO of Two Trees Consulting, is a public speaker and health care consultant. She is the former President and Chief Executive Officer of Amylin Pharmaceuticals and the former Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer.
Ginger received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA from Harvard University.
Ms. Graham serves on the Boards of Directors for Amylin Pharmaceuticals, Proteus Biomedical Pharmaceutical Systems Division, ICAT Managers, Sierra Neuropharmaceuticals, Inc., Genomic Health, Inc., the American Diabetes Association Research Foundation where she serves as Vice Chair, and the California Council on Science and Technology. She also serves on the Advisory Boards for Bente Hansen Inc., the Kellogg Center for Executive Women and the Women Business Leaders of the US Health Care Industry Foundation. Ms. Graham is a member of the Harvard Business School Board of Dean’s Advisors, the Harvard Business School Health Industry Alumni Advisory Board, The University of Arkansas Board of Dean’s Advisors, the University of Arkansas Alumni Association Board of Directors and the University of California, San Diego Health Sciences Advisory Board. She serves on the Editorial Advisory Board for the Journal of Life Sciences publication, frequently speaks at Business Schools and has written for Harvard Business Review.
An avid gardener and horsewoman, Ginger lives with her husband, Jack, in Boulder, Colorado. She devotes much of her free time to mentoring high-potential young women in business and advancing the cause of women’s healthcare.
Karen Lane RN, MSN
Vice President, Care Management Operations – American Healthways
Karen has twenty years of experience in healthcare ranging from clinical administration, to the entrepreneurial leadership of a national consulting company and most recently, to overseeing the high risk care management division of one of the country’s fastest growing publicly traded companies.
Karen started her career at Sharp Healthcare where she served as Executive Director of Nursing. There she had budgetary responsibility for over $18 million, and was responsible for all medical and surgical units, the case management department, and ambulatory and outpatient departments.
She formed Armstrong Lane Consulting out of the need for a managed care infrastructure for hospitals, clinics and physician groups. The company’s mission was focused on managed care preparedness. Risks were assessed and work place re-design and system enhancement provided.
Karen joined Status One, a start up company which became the market leader provider of care management services for high risk populations. She was part of the due diligence team who eventually sold Status One to American Healthways. She is currently VP of Care Management Operations with responsibility for Status One Operations, and contributes to American Healthways new product development, sales and marketing, and international launch and expansion.
Her leadership has brought her the “Thomas Cigarran Values and Culture Award”, named after the founder and Chairman of the Board of American Healthways. The person selected epitomizes the values of the company and exhibits strong and inclusive leadership consistent with the culture of the company.
She is a member of the National Honor Society for Nurses, the National Honor Society for USD Nursing Graduates and on the board of Caring for Humanity.
CONNIE L. MATSUI
Connie Matsui recently retired as the executive vice president, knowledge and innovation networks at Biogen Idec Inc., one of the largest companies in the biotech industry. Prior to the merger of Biogen Inc. and IDEC Pharmaceuticals Corporation in November 2004, she was senior vice president of planning and resource development with IDEC. Biogen Idec discovers, develops and commercializes innovative therapies for oncology, rheumatology, neurology and immunology indications. more
Vincent Mudd, San Diego State University alumni, is the president and chief executive officer of San Diego Office Interiors, a business he has owned since 1994. Vincent, his wife Catherine and their talented staff have built San Diego Office Interiors into an award winning office interiors firm.
Vincent Mudd and his team created office intelligence® a turn-key process that offers a unique and veritable one-stop service for companies that are building new offices, lab space or bank branches. As a general contractor, licensed design firm, low voltage sub-contractor, project management company, modular construction expert and a provider of ergonomic FF&E products, San Diego Office Interiors can take an empty shell and create, permit, build and furnish the entire facility – one stop – therefore saving San Diego Office Interiors customers more time and more money. Services include: LEED Certified interior design and planning, tenant improvement construction, voice, data and network infrastructure, construction management; furniture and equipment acquisition and facility management services. Vincent believes that there is a nexus between sustainability, profit and productivity that can be best achieved by designing and building to LEED, LEAN and Six-Sigma standards. The business case is simple; sustainable planning, design and construction can be accomplished easily; increases operational efficiency and will add money to your bottom line.
Vincent is a master of creative options, bleeding edge ideas and problem solving. As a result, San Diego Office Interiors has a bevy of prominent local customers that include firms like Mesa Beverage, Pacific Western Bank, Corky McMillin, Seltzer Kaplan Attorneys at Law, Cymer and Barney & Barney as well as large national clients such as Capital One, Motorola, Wells Fargo Bank, L-3 Communications and Watson Wyatt. San Diego Office Interiors is flexible enough to configure itself to meet the specific needs of each customer by delivering its unique mix of products and services.
Vincent’s deeply rooted principles of commitment, trust, and the empowerment of people shine through not only in the day-to day-operations and management of his very successful business, but in his civic leadership and community activities as well. Gov. Schwarzenegger appointed Vincent to the 5 member State Compensation Insurance Fund Board in 2004, the largest Worker Compensation Insurer in the world. He also holds executive board positions with the San Diego Regional Chamber of Commerce, the San Diego Regional Economic Development Corporation, the American Red Cross, the YMCA, the Campanile Foundation at San Diego State University, the Workplace Alliance, San Diego’s Healthcare Coalition, KPBS Financial Advisory Committee, Big Brothers & Big Sisters and is a member of the City of San Diego Charter Review Committee an also a member of San Diego’s largest Rotary Club - Rotary Club 33.
Vincent has received the “Most Admired Company” award by the Office Furniture Dealer Alliance and was honored as “Man of the Year” by Big Brothers and Big Sisters and inducted into the Junior Achievement “Business Hall of Fame”. He was also awarded the “Healthcare Industry Supporter of the Year” by UCSD. In 2007, Vincent and San Diego Office Interiors won Ernst & Young’s Entrepreneur of the Year Award in Consumer & Business Products and inducted into the National Hall of Fame in the Real Estate and Construction Category. Back to Top
BO E. H. SAXBERG, M.D., Ph. D.
Pharmaceutical Consultant
Dr. Saxberg is originally from Seattle, Washington in the United States. He attended the University of Washington there, receiving Summa Cum Laude an Honors B.S. degree in Mathematics and an Honors B.S. degree in Chemistry. He then attended Cambridge University in England, earning an Honours B.A./M.A. Cantab. in Physics. Returning to the United States, he received an M.D. degree from Harvard and his Ph.D. in Physics from the Massachusetts Institute of Technology.
Dr. Saxberg was a National Institutes of Health Fellow at MIT from 1989 to 1991, prior to joining Eli Lilly in Indianapolis as a Senior Research Scientist, continuing his prior research interests in QSAR/genomics/proteomics/physiomics. In 1993, Dr. Saxberg was named Director of Information Sciences at Eli Lilly. This group subsequently led a number of industry pioneering efforts at Lilly, including the first Internet home page for a pharmaceutical company, as well as developing interactive health economic models evolving to disease management, point of care prescribing, and the development of information resources to support modern product portfolio resource allocation decisions.
Dr. Saxberg joined Johnson & Johnson in 1995 as Vice President, Corporate Staff, Advanced Communications, leading Johnson & Johnson’s efforts in Medical Informatics, focusing on new business opportunities related to information technology in healthcare delivery and product development. As part of these efforts, working with both internal and external venture capital resources as well as member companies, the Advanced Communications Group helped to develop for J&J pioneering creation or investment positions ranging from defined contribution employee benefit models of health insurance, real-time auto-adjudication networks at the point of care supporting cost-quality decisions between doctor and patient, and a variety of technologies in health informatics including telemedicine, clinical studies and outcomes measurement, and electronic medical records. Working with the J&J international pharmaceutical group, innovative programs were created in the development of iterative customer relationships based on clinical information, creating demonstration of product value. Dr. Saxberg and members of the Advanced Communications Group also led the development and implementation of Johnson & Johnson’s global policies and procedures for the Internet, including privacy policies, to construct a policy platform to enable future business needs.
As of 2002, Dr. Saxberg left Johnson & Johnson to become founder and Pres., DDO Strategic Services, LLC, (“Design Development Optimization”). He is continuing his prior work in consulting, venture formation and business development with companies seeking to take leading advantage of change driven by new technologies and information access in health care, with application to product research & development, product and service marketing, financial services innovation, and clinical service innovation. Dr. Saxberg is a management/advisory board member for a number of entrepreneurial companies, associations and venture firms, including PhDx, Exagen, Medidata, Boston Millennia Partners, Village Ventures, the Institute for the Future, and the Columbia University Center for Advanced Technology. Back to Top
Thomas H Silberg is a seasoned professional in the Healthcare Industry with 
substantial executive level experience, in major branded pharmaceuticals, medium sized biotech, start up biotech and generic IV drug manufacturing and commercialization. He has led multiple strategic transactions including a company divestiture, a public company spin out, asset acquisitions and partnerships. He has consistently grown both revenue and earnings characterized most recently by APP Pharmaceuticals revenue growth of 23.1% cagr (2005-2009). His leadership skills have guided companies through many organizational challenges ranging from building a start up biotech company to integrating a North America based company with a European based global healthcare organization. He has successfully managed numerous company reorganizations targeted at process improvement, creating new capabilities, building needed infrastructure and downsizing. (more)
Executive Vice President, JHG Townsend
Jacqueline Townsend is an expert in marketing and has a proven track record of positioning companies to take leadership roles in their industries. She is well-known for her ability to turn underdogs into market leaders. Jacqueline’s in-depth industry knowledge of the technology and wellness fields, coupled with her expertise in strategic market planning and execution, make her a powerful marketing ally. Jacqueline has guided numerous clients through the rigors of IPO and is adept at preparing businesses to meet and exceed the expectations of venture capitalists and potential stake holders.
She is the creator of the BrandTrack (TM) workshop, a program that has facilitated numerous market success stories. Jacqueline’s expertise has made her a sought-after speaker at both local and national industry and business events. She is the recipient of numerous awards, including the Small Business Association Entrepreneur of the Year, PR Week’s Public Relations Practitioner of the Year, TSector’s teleFUSION 03 PR Leader of the Year Award and a finalist for Ernst & Young’s Entrepreneur of the Year Award.
Jacqueline formed The Townsend Agency in 1993 and sold her business to JHG in July of 2007. Jacqueline has served on numerous boards. She currently holds the position of Vice Chair of the Board of Trustees for National University and the National University System and is on the private board of Restorative Remedies, LLC. Jacqueline earned a master’s degree in science, graduating summa cum laude from Wright State University. She also graduated summa cum laude with degrees in psychology and liberal studies from California State University, Long Beach.
Back to Top
GERI ANN WARNKE 
Geri Ann Warnke graduated from the University of Colorado School of Medicine with a degree in physical therapy. She was recruited by Mercy Hospital to join the staff of the burn unit; she later joined the orthopedic department at the La Jolla VA Hospital.
A few years later Warnke established her private practice in physical therapy and eventually opened her clinic in the Mercy medical building. In 2001 she elected to see patients privately in their homes, feeling that was the place for the optimum in care. For the past eight years, she has devoted her practice to seeing post-operative and injured patients in the La Jolla and Point Loma areas, using her skills and knowledge with her many years of practice. She has a vibrant practice, due to her unique clinical and personal style. She works closely with the physician and sets the maximum results for patients.
Geri’s passion has been her work in the non-profit sector. She has worked tirelessly for the organizations with which she has been involved. She has been president of the boards of the La Jolla Playhouse, the Sidney Kimmel Cancer Center and, most recently, the Rotary Club of San Diego where she provided her strong leadership to helping the Club move toward a strategy for the future. She is married to Dr. Joseph. F. Kennedy and has a 23-year old son who graduated from UC Santa Cruz in environmental studies. She and Joe are avid walkers, tackling Mt Soledad on a regular basis.
RANDALL E. WOODS
President and Chief Executive Officer, Sequel Pharmaceuticals, Inc.
Randall E. Woods is currently the President, Chief Executive officer, and a member of the board of directors of Sequel Pharmaceuticals, Inc. Sequel is a privately held, clinical stage pharmaceutical company that was created by spinning out a Phase II-ready compound from NovaCardia, to be developed as a novel therapy for atrial fibrillation, one of only two major cardiovascular disease conditions increasing in incidence, prevalence and mortality. Sequel has successfully raised $20 M in a Series A round.
Prior to joining Sequel, Mr. Woods served as the President and Chief Executive officer of NovaCardia, Inc. from May 2004 until September 2007. From May 1996 to July 2003, Mr. Woods served as the Chief Executive officer of Corvas International, Inc., a biopharmaceutical company that focused on cancer and cardiovascular disease, which was acquired by Dendreon Corporation.
Prior to his employment at Corvas, Mr. Woods served as the President of the United States Operations of Boehringer Mannheim Pharmaceuticals Corporation from March 1994 to March 1996, and was Vice President of marketing and sales at Boehringer Mannheim from December 1993 to February 1994. Prior to that, he served in various capacities at Eli Lilly and Company from 1973 to December 1993. Mr. Woods currently serves as the Chairman for the Advisory Board of the University of California, San Diego’s Sulpizio Family Cardiovascular Center and serves on the board of directors of BIOCOM, a life science industry association in Southern California. Mr. Woods holds a B.S. degree in biology from Ball State University and an M.B.A. from Western Michigan University.